CAS 1197996-80-7 appears in our catalog under these names: CBL0137, CBL0137/ 98%, CBL 0137, CBL0137, 99.73%, 1,1′-[9-[2-[(1-Methylethyl)amino]ethyl]-9H-carbazole-3,6-diyl]bis[ethanone], 98%. Offered by: GLPBio, TargetMol, Biosynth, MedChemExpress, Chemat. Available pack sizes: 10mg, 2mg, 25mg, 5mg, 50mg, 1mg, 100mg, 100 mg.
CBL0137 is a member of the class of carbazoles that is 9H-carbazole which is substituted by acetyl groups at positions 3 and 6, and by a 2-isopropylethyl group on the nitrogen atom (position 9). It is a modulator of histone chaperone FACT (FAcilitates Chromatin Transcription) - interaction of CBL0137 with the FACT complex results in simultaneous NF- beta suppression, Heat Shock Transcription Factor 1 (HSF1) suppression and p53 activation - and shows antitumour effects in animal models of various cancers. It has a role as an antineoplastic agent, an apoptosis inducer, a NF-kappaB inhibitor and a p53 activator. It is a member of carbazoles, a secondary amino compound, a tertiary amino compound, a methyl ketone and an aromatic ketone.
Source: ChEBI
| Molecular formula | C21H24N2O2 |
|---|---|
| Molecular weight | 336.4 g/mol |
| IUPAC name | 1-[6-acetyl-9-[2-(propan-2-ylamino)ethyl]carbazol-3-yl]ethanone |
| InChIKey | JKCSODVERGVDLT-UHFFFAOYSA-N |
| SMILES | CC(C)NCCN1C2=C(C=C(C=C2)C(=O)C)C3=C1C=CC(=C3)C(=O)C |
Computed by PubChem (NCBI)